Beginning the Journey into the World of Small SCs
Very small embryonic-like stem cells (VSELs) were initially identified by our group in adult murine bone marrow (BM) as a rare population of stem cells (SCs) with embryonic characteristics. Our journey toward their identification and isolation started in 2001, provoked by increasing enthusiasm at that time concerning the “SCs plasticity theory.” We hypothesized that the existence of an unidentified, nonhematopoietic population of BM cells could alternatively explain the regenerative capacity claimed to be the result of trans-dedifferentiation or plasticity of hematopoietic (H)SCs (1–3). We suspected that such cells would reside in adult tissues and display broad differentiation potential. Thus, our first challenge was to identify multipotent or even pluripotent adult SCs in adult BM that would be endowed with a broad differentiation potential to various nonhematopoietic tissues. We assumed that one of the markers on the surface of these cells would be a G-protein-coupled seven trans-membrane span CXCR4 receptor that binds α-chemokine stromal derived factor-1 (SDF-1). As no good working antibody for murine CXCR4 was available at that time, we performed chemotactic assays on BM nucleated cells (BMNCs) to SDF-1 gradient. We learned that BM contains very rare, primitive CXCR4+ SCs that respond by chemotaxis to SDF-1 and that these cells are different from classical HSCs (3, 4).
Developmental Hierarchy of SCs
SCs are a pool of unique cells that possess the capability of self-renewal and the ability to differentiate into cell lines that are committed to particular developmental pathways (5–7). From the first stages of embryonic development up to adulthood, the pool of SCs residing in the body is hierarchically organized according to the cells' differentiation capacities (7, 8). The most primitive SC is the zygote, which results from the fusion of two gametes during the process of fertilization. The totipotent zygote has the capability to give rise not only to all tissues of an embryo but also to extra-embryonic placental tissues. Subsequently, the cells in the morula (embryo at <32-cell stage) have already lost their totipotency, but preserve their ability to differentiate into cells from all three embryonic germ layers, that is, the ecto-, endo-, and mesoderms. Such cells are defined as pluripotent (P)SCs and can contribute to all the tissues of the developing embryo. PSCs are also identified in the next stages of embryonic development in the inner cell mass (ICM) of the blastocyst (9–11) and as cells of the proximal primitive ectoderm (epiblast) in the developing gastrula (12, 13). Subsequent stages of gastrulation lead to the development of three distinct germ layers (ecto-, endo-, and mesoderms), which contain three different SC types specific for each of them. These germ layer-specific SCs are called multipotent and may give rise to monopotent SCs that are specific for tissues and organs developing from this particular germ layer. For example, the multipotent mesodermal SCs give rise to monopotent hematopoietic, skeletal muscle, heart, endothelial, and mesenchymal tissue-committed SCs, the multipotent endodermal SCs give rise to monopotent liver, pancreas, and gut epithelium, while the ectodermal multipotent SCs give rise to monopotent brain, peripheral ganglions and nerves, eye, epidermis, and skin tissues (14).
Generally, while the monopotent and tissue-committed SCs were described in adult tissues, SCs with pluripotent/multipotent capacity were thought to be restricted to the early embryonic stages. However, recent evidence challenged this idea by confirming the presence of pluripotent/multipotent SCs in adult tissues and organs (15–19). Several groups postulated that the BM is enriched for this population.
The Hunt for PSCs in the BM
The BM is a major organ harboring HSCs that maintain adult hematopoiesis (20). As mentioned above, the population of BM-derived HSCs has been postulated to be the source of hematopoietic- and multiple nonhematopoietic lineages (21). This assumption established a basis for the SC plasticity hypothesis and was supported by several promising results where HSCs were employed for regeneration of injured organs in animal models, for example, after myocardial infarct (22), stroke (23), spinal cord injury (24), and liver damage (25). The “plasticity theory” raised much hope that HSCs harvested from BM, mobilized peripheral blood (mPB), or cord blood (CB) could become a universal source of SCs for tissue and organ repair.
However, despite these initial promising results, the role of HSCs in the repair of nonhematopoietic tissues became controversial (26–28). Further experiments with highly purified populations of HSCs showed no effects in myocardial or central nervous system regeneration (29, 30). Following these unexpected results, the scientific community became polarized on the phenomenon of “plasticity.” The alternative theory that BM may also contain some non-HSCs, which could explain BM plasticity, has been adopted by several investigators including our group (3, 27, 28). Thus, from beginning, we believed the adult BM, CB, or mPB contained unidentified, rare, primitive SC populations that were responsible for some of the positive results that demonstrated SC plasticity when HSCs “contaminated” by these other SCs were employed.
Digging in the Extended Lymphgate: Novel Criteria for Isolating VSELs
We began our search for VSELs in the suspension of BMNCs by employing a novel fluorescence activated cell sorting (FACS)-based isolation strategy (3, 31, 32). Encouraged by our initial chemotactic isolation experiments, we assumed that the most primitive SCs would express CXCR4 receptor (3, 4). We also assumed that they would express some of the pan-SC markers such as Sca-1 (in mice) and CD133/CD34 (in humans) (2, 31, 33). Furthermore, we hypothesized that both murine and human VSELs would belong to the nonhematopoietic compartment of the BM, and as such, would lack the expression of CD45 (pan-hematopoietic marker) as well as other hematopoietic lineage markers (Lin−). Moreover, the cellular size became one of the major criteria for VSELs' isolation (31, 32). The morphological characteristics of primitive PSCs present in the epiblast of the preimplantation blastocyst as well as our chemotactic isolation experiments (3, 4), which that revealed a presence of some very rare, unusually small SDF-1-responsive SCs in a population of BMNCs, led us to believe that that these cells will be included in the extended “lymphgate.” This gate includes lymphocytes based on their forward- (FSC) and side scatter characteristics (SSC) or cytogram (FSC vs. SSC flow cytometric dot-plot). Table 1 summarizes major preparatory steps to isolate murine and human VSELs.
|CELLS||MURINE VSELs||HUMAN VSELs|
|SOURCE||BONE MARROW (BM)||CORD BLOOD (CB)|
|Major isolation steps||1. Flushing cavities of femurs, tibias, and hip bones||1. Collecting of CB in presence of heparin|
|2. Lysis of erythrocytes with 1× BD pharm lyse buffer (BD Pharmingen)||2. Double lysis of erythrocytes with 1× BD pharm lyse buffer (BD Pharmingen);|
|3. Immunofluorescence staining and FACS sorting||3. Depletion of Lin+ cells by MACS sorting following staining with lineage cell depletion kit (MiltenyiBiotec)a|
|4. Immunofluorescence staining and FACS sorting.|
|Antibody for flow cytometry||1. Anti-mouse-Ly-6/E (Sca-1)||1. Anti-human-CD133 (MiltenyiBiotec)|
|2. Anti-mouse-CD45||2. Anti-human-CD45|
|3. Anti-mouse-“lineages cocktail”: CD45R/B220, Gr-1, TCRαβ, TCRγδ, CD11b, Ter119 (all antibodies from BD Biosciences)||3. Anti-human- “lineages cocktail”: CD2, CD3, CD14, CD66b, CD24, CD56, CD16, CD19, CD235a (all antibodies from BD Biosciences).|
|Key points||Depletion of red blood cells on Ficoll-Paque gradient should be avoided because some fraction of VSELs can be lost during such isolation. Lysis in hypotonic solution is recommended.||Depletion of red blood cells on Ficoll-Paque gradient should be avoided because some fraction of VSELs can be lost during such isolation. Lysis in hypotonic solution is recommended.|
Figure 1 demonstrates our overall FACS-based strategy for VSELs isolation. As mentioned above, based on the predicted very small size of these cells, we employed an innovative sorting strategy by extending the typical lymphgate into the area of a dot-plot typically thought to contain mostly “cellular debris” (31, 32) (Fig. 1A). For further analysis and sorting, as shown on Panel A, we employed a mixture of predefined sized synthetic beads (1, 2, 4, 6, 10, and 15 μm in diameter) to focus on all objects between 2–10 μm in size (32) (Fig. 1A). This region mostly contains cell debris, and also some rare nucleated cellular events. Further analysis of this expanded gate identified a very rare fraction of nonhematopoietic murine cells (0.030% ± 0.008% of total BM cells), which expressed SC antigen 1 (Lin−/CD45−/Sca-1+) (31, 32).
A similar strategy has been employed for the isolation of human CB-derived VSELs (CB-VSELs) (Fig. 2). Lin−/CD45−/CD133+/CD34+/CXCR4+ CB-VSELs have been identified when all objects larger than 2 μm were included into analysis and further sorting by FACS (32–34).
VSELs: “Missed Pearls” that are Smaller than Erythrocytes but Larger than Platelets
We employed a multidimensional methodological approach for further morphological and molecular characterization of murine and human VSELs. Transmission electron microscopic (TEM) analysis supported our initial observation that both murine and human VSELs are very small in size (31, 33). Accordingly, murine BM-derived VSELs were found to be ∼2–4 μm in diameter, while purified murine HSCs (Lin−/CD45+/Sca-1+) were much larger (∼6–8 μm). Similar measurements were obtained by confocal microscopic analysis of murine BM-derived VSELs and HSCs (32). Furthermore, when detailed flow cytometric analyses of sorted VSELs and HSCs were performed, we observed that 95.24% ± 0.94% of Sca-1+/Lin−/CD45− (VSELs) were located in the gate, including objects within the 2–6 μm size range, while 85.82% ± 1.28% of Sca-1+/Lin−/CD45+ (HSCs) were found in the 6–10 μm size range (32). As most sorting protocols exclude events smaller than 6 μm in diameter because of the assumption that they contain cell debris, erythrocytes and platelets, it is conceivable that the very small size of VSELs precluded the identification of these “missed pearls” for many years (32, 35).
To better support the existence of such small eukaryotic cells in BM, we focused on determining the exact size and morphological characteristics of VSELs. We employed ImageStream system (ISS) to precisely calculate the size of VSELs and compared them to other cell types found in BM and peripheral blood (PB) including erythrocytes, platelets, and leukocytes (32, 35).
The ISS technology was developed as a novel method for multi-parameter cell analyses and as a supportive tool for flow cytometry. The ISS integrates the features of flow cytometry and fluorescent microscopy by analyzing a multitude of objects in suspension and collecting their acquired images for offline digital image analyses (36–38). Several applications on the system have been already developed on top of its unique capabilities (37, 39–42). Recently introduced multi-laser upgrade of the instrument allows employing of wide range of fluorochromes/dyes and multicolor analyzes, while the presence of new extended depth of field (EDF) technology increases resolution and improves precision of analysis enabling many new applications of the system including counting FISH spots in suspension (42–44).
On the basis of direct visualization of acquired objects by ISS, we confirmed that some of the isolated very small Sca-1+/Lin−/CD45− objects contain nuclei and posses cellular features characteristic for VSELs. ISS analysis allowed the precise calculation of the VSELs' size, which was found to be 3.63 ± 0.14 μm in diameter, and confirmed the larger diameter of Sca-1+/Lin−/CD45+ HSCs (6.54 ± 0.17 μm) (32). Similarly, we calculated the average size of human CB-VSELs as 6.58 ± 1.09 μm (unpublished). When the inter-species differences in cellular sizes are considered, this corresponds to the size of murine VSELs.
Moreover, direct comparison of different cell type images in the same scale combined with digital image analysis confirmed that VSELs are larger than PB platelets but smaller than erythrocytes (Fig. 3). This is the first report of the existence of cells smaller than PB erythrocytes in adult tissues of murine (Fig. 3B) as well as human (Fig. 3C) (8, 32, 35).
VSELs: “Are They the Almighty PSCs?”
Initially, direct electron microscopic analyses of both murine and human VSELs revealed their very small size and several characteristics typical for ESCs. These included a large nucleus surrounded by a narrow rim of cytoplasm, an open-type chromatin (euchromatin) (31, 33), and a high nuclear-to-cytoplasmic (N/C) ratio. This high N/C ratio is typically considered to be a feature of developmentally primitive SCs (32).
Further analysis established that VSELs express markers of PSCs identified in the embryonic stages on both the mRNA and protein levels as determined by real time RT-PCR and immunocytochemistry, respectively (31, 32). Accordingly, we detected the presence of SSEA-1, Oct-4, Nanog, Rex-1, Dppa3, and Rif-1 in mice cells (31, 32) and SSEA-4, Oct-4, and Nanog in human cells (33). Of note, we employed Oct-4-specific primers that do not amplify Oct-4 pseudogenes as well as Oct-4-specific antibodies (31, 33).
Moreover, we established that VSELs express several markers of PGCs, which are a mobile population of epiblast cells giving rise to gametes after migration into the genital ridges of the developing embryo. Murine VSELs express the placental form of alkaline phosphatase (PLAP), Stella, Fragilis, Nobox, and Hdac6 as well as CXCR4, which indicates their close relation to a population of epiblast-derived PGCs (8, 14). In conclusion, both the primitive features of these cells as well as their expression of several embryonic markers justify the name we gave to these cells (31).
In addition, the presence of CXCR4, as well as other chemoattractants' receptors such as c-met and LIF-R, indicates the high migratory capability of VSELs toward the gradients of SDF-1, hepatocyte growth factor (HGF), and leukemia inhibitory factor (LIF), respectively (4, 31). The motility of VSELs is crucial not only for their mobilization into PB after tissue injury (45, 46) or pharmacological mobilization (47), but also supports our hypothesis about their deposition in various organs as a consequence of their migration during embryonic development (14).
Despite their small size, VSELs possess diploid number of chromosomes. They not only express multiple markers of pluripotency but also exhibit the potential of PSCs in vitro (31, 48, 49). Accordingly, when cultured in predefined differentiation media, VSELs exhibit the potential to give rise into cells from all three germ layers such as ectodermal neural cells, endodermal pancreatic cells, and mesodermal cardiomyocytes (31). Furthermore, freshly isolated VSELs have been shown to improve the function of ischemic heart tissue when injected directly into an injured organ, as shown in the model of murine acute myocardial infarction (48).
Moreover, when cultured in direct contact over a feeder layer of C2C12 murine sarcoma cells, murine BM-derived VSELs are able to form cellular clusters and spheres resembling embryoid bodies [VSEL-derived spheres (VSEL-DS)] (31). Cells derived from such clusters preserve the pluripotent capacity of VSELs and differentiate into cells from all three germ layers. Culture of VSELs in the presence of C2C12 cells allows their expansion for more efficient, potentially regenerative therapeutic applications in vivo. Our experience in the treatment of ischemic heart tissues with expanded and ex vivo predifferentiated VSELs (those committed into cardiac lineage) indicate their higher beneficial effects after ex vivo preparation when compared with freshly isolated, quiescent VSELs (49).
Moreover, our recent experiments revealed that VSELs isolated initially as non-HSCs from the BM may finally differentiate if cultured in a permissive environment into HSCs. This observation additionally supports their pluripotent nature (8). Accordingly, we found that VSELs freshly isolated from BM do not reconstitute hematopoiesis in lethally irradiated mice (31, 50). When cultured in the presence of an OP-9 feeder layer (cell line that supports hematopoietic differentiation of established ESC lines), these cells grow cobblestone areas that contain HSCs developing de novo from VSELs. More importantly, HSCs that are expanded from VSELs grow hematopoietic colonies in vitro and reconstitute hematopoiesis in vivo after transplantation in lethally irradiated mice. Thus, VSELs possess properties of long repopulating HSCs (8). Their role in the potential turn over of HSCs in murine BM both in steady state and stress conditions is currently investigated in our laboratory.
Of considerable note, we identified VSELs not only in BM (31, 32), mPB (46, 47), and CB (33), but our recent research revealed the presence of VSELs in other adult tissues as well (35, 51). The Oct-4+/Lin−/CD45−/Sca-1+ VSELs were identified in the major organs of murine adults, predominantly in brain, kidneys, pancreas, and skeletal muscles (Fig. 4). Additionally, preliminary in vitro data suggest that VSELs sorted from spleen, thymus, and fetal liver form VSEL-DS similarly to those isolated from BM (35, 51). However, the pluripotent nature of Oct-4+/Lin−/CD45−/Sca-1+ VSELs derived from nonhematopoietic organs requires further investigation. In particular, because brain contains a highest number of VSELs, further studies are needed to compare these cells with neural stem cells that reside in hippocampus and subventricular region (52–54), as well as to asses the potential role of brain-derived VSEL in brain regeneration.
The Embryonic Heritage of VSELs: A Hypothesis About Their Embryonic Origin
Accumulating evidence demonstrates the presence of stem cells that express markers of very early developmental stages in multiple adult tissues. The presence of Oct-4+ cells that are markers of pluripotency has been described in adult BM (15, 18, 31), epidermis (16, 19), bronchial epithelium (17), myocardium (55), pancreas (56), and testes (57, 58). In agreement with these observations, we discovered Oct-4+ VSELs in multiple adult tissues (35, 51). On the basis of the pluripotent nature of VSELs, their mobile character, and phenotypical similarities with PGCs, we hypothesize that VSELs may originate from the migrating epiblast-derived pluripotent (EP)SCs.
To support this notion, the epiblast has been described as a source of PSCs for all three germ layers and PGCs during gastrulation. We hypothesize that migrating EPSCs can be deposited in the developing peripheral tissues and organs and that they may serve as a reserve pool of quiescent PSCs (14). These cells may participate in cellular turnover and the rebuilding pool of the tissue specific progenitors, especially under urgent circumstances such as tissue injury (14). On the other hand, such primitive SCs may potentially initiate carcinogenesis when their potential becomes unleashed under conditions that are still poorly understood. Development of multiple types of primitive tumors such as teratomas, germinomas, and pediatric sarcomas that express several markers characteristic for epiblast/germ line cells supports this theory (8). However, the mechanisms controlling the quiescence of PSCs in adult tissues remain unknown. We are currently examining the EPSC's origin of VSELs in our laboratory.
BM as a Home of Versatile Primitive SCs: Are VSELs the New Kids on the Block?
Recently, several populations of nonhematopoietic primitive SCs have been described in the BM and other adult tissues (Table 2) including: (i) mesenchymal (M)SCs; (ii) multipotent adult progenitor cells (MAPCs); (iii) marrow-isolated adult multilineage inducible (MIAMI) cells; (iv) multipotent adult (MA)SCs; and (v) endothelial progenitor cells (EPCs). It is conceivable that these cells are the same or overlapping populations of SCs that have been described by different investigators and given various names according to circumstance. These cells and their potential relevance to VSELs will be briefly discussed below.
|Endothelial progenitor cells (EPC)||Human—CD133+, CD34+, c-kit (CD117)+, VE-cadherin+, VEGFR2+, CD146+, vWF+, CD31+|
|Mice—Sca-1+, c-Kit (CD117)+, Lin−, VEGFR2+, VE-cadherin+, Tie2+, CD146+, vWF+, CD31+|
|Mesenchymal stem cells (MSC)a||International Society for Cellular Therapy criteria: CD105+, CD73+, CD90+, CD45−, CD34−, CD14−, CD11b−, CD79a−, CD19−, HLA-DR−|
|Other additional markers: Stro-1+, SB-10+ (CD166), SH-2+ (epitope on CD105), SH-3+ (epitope on CD73), SH-4+ (epitope on CD73), CD44+, CD29+, CD31−, vWF−|
|Markers of most primitive MSC: CXCR4, CD133, CD34 (?), p75LNGFR|
|Multipotent adult progenitor cells (MAPC)a||SSEA-1+, CD13+, Flk-1low, Thy-1low, CD34−, CD44−, CD45−, CD117(c-kit)−, MHC I−, MHC II−|
|Marrow-isolated adult multilineage inducible cells (MIAMI)a||CD29+, CD63+, CD81+, CD122+, CD164+, c-met+, BMPR1B+, NTRK3+, CD34−, CD36−, CD45−, CD117 (c-kit)−, HLA-DR−|
|Multipotent adult stem cells (MASCs)a||CD13+, CD49b+, CD90+, CD73+, CD44+, CD29+, CD49a+, CD105+, MHC I+, HLA-DR−, CD14−, CD34−, CD45−, CD38−, CD133−, c-kit (CD117)−|
|OmniCytes||CD34+, CD133+, CXCR4+, c-Met+, CD33low, CD38low, MHC-IIlow|
|Very small embryonic like (VSEL) stem cells||CXCR4+, AC133+, CD34+, SSEA-1+ (mouse), SSEA-4+ (human), AP+, c-Met+, LIF-R+, CD45−, Lin−, HLA-DR−, MHC I−, CD90−, CD29−, CD105−|
MSCs have been identified and well characterized as a population of BM-derived adherent cells capable of differentiating into multiple mesodermal lineages (59, 60). Our data indicate a robust interaction of VSELs with BM-derived stroma that results in emperipolesis of VSELs inside the stroma-derived fibroblasts (31).
MAPCs have been isolated from a fraction of BMNCs as an adherent fibroblast-shaped population of CD45−GPA-A− cells (61). MAPCs have been depicted as pluripotent cells capable of differentiating into cells from all three germ layers and contributing to all embryonic tissues when injected into a developing blastocyst (61).
MIAMI cells are an adherent human adult BM population that expresses ESC markers Oct-4 and Rex-1, while their cultured colonies express several markers characterizing cells from all three germ layers (62). However, their ability to contribute to tissues of the developing blastocyst as well as their further morphological characterization on the single cell level has not been examined.
Similarly, MASCs have been recently identified as adult SCs with pluripotent characteristics and the capability to differentiate into cells from multiple lineages in vitro. They were cloned from human adult BM as well as other tissues including the liver and heart (63). MASCs express typical MSCs markers and expand in MSC-supporting media.
Finally, EPCs identified in both murine and human BM are mobilized in response to tissue injury (64, 65). Because VSELs are mobilized during tissue and organ injuries and a high antigenic similarity between VSELs and EPCs exists, they can be potentially co-isolated with EPCs.
The potential relationship between MSCs, MAPCs, MIAMI cells, MASCs, and EPCs is not clear, although it is possible that these are overlapping populations identified by different isolation and expansion strategies. On the other hand, these populations are largely derived from the adherent fraction of BM cells that potentially could contain attached or internalized VSELs by a process of emperipolesis. The appealing potential interaction between VSELs and the aforementioned stem/primitive cell populations is very intriguing and requires further investigation.
Other Small SCs Described in Adult Tissues
Although SCs have been traditionally described as “small lymphocytes,” the exact size of SC and primitive SC populations was rarely measured. The vast majority of the available literature describes the morphology and particularly the size of stem/primitive cells in comparison to more mature cells from the same tissue or organ. Therefore, the relatively small size of stem/primitive cells has rarely been assessed with precision.
Based on our observation, the term “small SCs” should be only used to describe cells that are smaller than red blood cells. This is a criterion we use in our work with murine and human VSELs. By employing the ISS, we calculated the size of murine and human VSELs as 3.63 ± 0.27 μm and 6.58 ± 1.09 μm, respectively, while murine and human erythrocytes are 4.94 ± 0.46 μm and 7.87 ± 1.54 μm in diameter, respectively (32, 35, 66).
Other “Small SCs” Isolated from Murine Tissues
The first description of small cells with such primitive morphology in the murine BM was published in the late 1980s. These cells were usually described in the context of subpopulations from the most primitive HSCs.
BM mononuclear cells-derived progenitor-like cells
By employing electron microscopic analysis, Matsuoka and Tavassoli (67)identified the existence of cells in the BM mononuclear cell fraction that were between 4 and 5 μm in size. These small cells exhibited some morphological features characteristic for hematopoietic progenitors.
Lin−/Rhdull/Hodull long-term repopulating HSCs
At the same time, Radley et al. (68) described a population of very primitive HSCs isolated from the murine BM that were capable of long-term hematopoietic reconstitution. These cells were characterized by a lack of hematopoietic lineage markers and their ability to exclude both Rhodamine 123 (Rhdull) and Hoechst 33342 (Hodull) dyes. The average size of these cells was estimated by TEM analysis as ∼4.6 μm. Interestingly, these cells could be separated into in three different subpopulations with one of them being very similar to the murine BM-derived VSEL phenotype (68). We have noticed that VSELs exclude Rhodamine 123 and Hoechst 33342 dyes. As such, it is possible that by sorting HSC with above-mentioned characteristics in these experiments, some VSELs were coisolated as well.
Lin−/ALDHhigh long-term repopulating HSCs
In the 1990s, Jones et al. (69, 70) isolated a population of small long-term repopulating HSCs by employing elutriation followed by FACS based on the high activity of aldehyde dehydrogenase (ALDHhigh) and a lack of hematopoietic lineage markers. The criteria for elutriation were optimized to obtained the fraction of the smallest lymphocytes and separate them from the more mature hematopoietic progenitors (69–71). Although the size of these cells was not published in the original publication, a recent article from this group described that these SCs are smaller than 5 μm (72). Unfortunately, these interesting cells were never analyzed for expression of potential ESC markers. It is very likely that they share several characteristics with VSELs.
The presence of cells with a similarly small size as murine VSELs (<5 μm) has been recently postulated by Vacanti et al. (73) These small cells were isolated from adult murine tissues and described as “spore-like SCs.” The authors challenged the idea that erythrocytes are the smallest cells in the adult body. Unfortunately, the isolation strategy of spore-like SCs and their exact markers has not been described by the authors. It is likely that these cells are closely related to VSELs.
CD45−Sca-1+c-kit− cells with pluripotent characteristics
By employing flow cytometric analysis of single cell suspensions from murine brain, blood, and intestinal epithelium, Howell et al. (74) unveiled the presence of very small CD45−Sca-1+c-kit− cells that may represent universal PSCs residing in multiple murine tissues. However, the authors did not reveal an exact size of these interesting cells.
Other “Small SCs” Isolated from Human Tissues
Recently, several studies have indicated the presence of small SCs in human tissues that correspond to our VSELs.
Small round ovarian surface epithelium SCs
Virant-Klun et al. (75) described very small SCs with pluripotent characteristics in the human ovarian surface epithelium. These cells are small round cells (2–4 μm) and express embryonic markers such as SSEA-4, Oct-4, Nanog, Sox-2, and c-kit and can form embryoid body-like structures in vitro. It is very likely that these cells correspond to a population of human VSELs.
Small CB-derived SCs
Recently, McGuckin et al. (76) demonstrated the presence of very small SCs in umbilical CB and estimated the size of these cells at 2–3 μm. These cells exhibit pluripotent characteristics such as the expression of Oct-4 and Sox2 and have neural differentiation potential. Despite the elegant and detailed isolation and culture protocols, the authors did not provide the information regarding the methodology employed for size calculation, and the majority of images presented in the article do not contain a scale. In our findings, a similar population of cells (human CB-VSELs) is slightly larger in size.
Other Small Cells
Interestingly, Huang et al. (77) while isolating MSCs on a double layer culture plate containing 3-μm pores that were employed to sieve out the relatively large MSCs, described a population of very small cells residing in the human BM. These very small cells were able to migrate through such small pores. However, the authors have never further investigated and characterized these cells.
Similarly, it was also reported that MAPCs may contain a subpopulation of very small cells that express ESC markers (78). Further characterization of these small embryonic-like MAPCs is needed to address their potential similarity to VSELs.